Manuel Cuenca‐estrella
#152,077
Most Influential Person Now
Manuel Cuenca‐estrella's AcademicInfluence.com Rankings
Manuel Cuenca‐estrellaphilosophy Degrees
Philosophy
#8445
World Rank
#11831
Historical Rank
Logic
#5478
World Rank
#6883
Historical Rank
Manuel Cuenca‐estrellabiology Degrees
Biology
#11436
World Rank
#14830
Historical Rank
Microbiology
#651
World Rank
#720
Historical Rank
Download Badge
Philosophy Biology
Why Is Manuel Cuenca‐estrella Influential?
(Suggest an Edit or Addition)Manuel Cuenca‐estrella's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study (2020) (1402)
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (2019) (1062)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (2012) (1017)
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. (2018) (801)
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. (2014) (710)
- Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 (2005) (616)
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗ (2008) (579)
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations (2007) (439)
- Saccharomyces cerevisiae fungemia: an emerging infectious disease. (2005) (434)
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. (2014) (387)
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). (2012) (371)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. (2012) (343)
- Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? (2008) (312)
- Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi (2006) (294)
- Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. (2005) (286)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). (2012) (280)
- Fungal Cell Gigantism during Mammalian Infection (2010) (280)
- Identification of Two Different 14-α Sterol Demethylase-Related Genes (cyp51A and cyp51B) in Aspergillus fumigatus and Other Aspergillus species (2001) (272)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. (2012) (267)
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. (2014) (251)
- Aspergillus Section Fumigati: Antifungal Susceptibility Patterns and Sequence-Based Identification (2008) (244)
- Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003 (2006) (240)
- A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus (2003) (237)
- EUCAST DEFINITIVE DOCUMENT E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds (2008) (229)
- Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival (2008) (220)
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus (2008) (215)
- Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs (2004) (207)
- Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. (2009) (205)
- Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. (2008) (204)
- Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. (1999) (202)
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole (2012) (200)
- Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts (2003) (195)
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent? (2013) (195)
- Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. (2014) (193)
- Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts (2012) (178)
- Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species (2004) (177)
- Susceptibility Patterns and Molecular Identification of Trichosporon Species (2005) (176)
- Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media (2009) (164)
- Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. (2009) (158)
- Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis: Results from Population-Based Surveillance of Candidemia in Spain (2008) (146)
- Invasive fungal infections in solid organ transplant recipients. (2014) (145)
- Combinations of antifungal agents in therapy--what value are they? (2004) (145)
- International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole (2005) (144)
- Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens (2011) (144)
- The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug (2014) (143)
- In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. (2005) (143)
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document) (2011) (143)
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution (2012) (135)
- Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). (2003) (134)
- The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole. (2009) (130)
- Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. (2015) (130)
- Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU* (2014) (129)
- Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study) (2013) (128)
- Detection and investigation of invasive mould disease. (2011) (128)
- Correlation of the MIC and Dose/MIC Ratio of Fluconazole to the Therapeutic Response of Patients with Mucosal Candidiasis and Candidemia (2007) (126)
- Comparative Evaluation of NCCLS M27-A and EUCAST Broth Microdilution Procedures for Antifungal Susceptibility Testing of Candida Species (2002) (126)
- Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile (2013) (123)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. (2012) (123)
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine (2012) (123)
- G484S Amino Acid Substitution in Lanosterol 14-α Demethylase (ERG11) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate (2003) (120)
- Targeted Gene Disruption of the 14-α Sterol Demethylase (cyp51A) in Aspergillus fumigatus and Its Role in Azole Drug Susceptibility (2005) (119)
- Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. (2002) (118)
- Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp. (2013) (116)
- Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011 (2013) (114)
- Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing Proposed Standard and the E-Test with the NCCLS Broth Microdilution Method for Voriconazole and Caspofungin Susceptibility Testing of Yeast Species (2002) (114)
- Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis. (2014) (111)
- Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. (2005) (109)
- Inoculum Standardization for Antifungal Susceptibility Testing of Filamentous Fungi Pathogenic for Humans (2001) (107)
- The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. (2013) (106)
- Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative (2015) (106)
- EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole. (2012) (104)
- Triazole Resistance in Aspergillus spp.: A Worldwide Problem? (2016) (103)
- Triazole Resistance in Aspergillus Species: An Emerging Problem (2017) (103)
- Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study) (2013) (102)
- EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents. (2016) (101)
- Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus. (1998) (99)
- Candidemia in Neonatal Intensive Care Units: Barcelona, Spain (2006) (99)
- Antifungal Susceptibility Profile of Cryptic Species of Aspergillus (2014) (99)
- Cryptococcus neoformans Capsular Enlargement and Cellular Gigantism during Galleria mellonella Infection (2011) (98)
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases. (2014) (98)
- Value of Serial Quantification of Fungal DNA by a Real-Time PCR-Based Technique for Early Diagnosis of Invasive Aspergillosis in Patients with Febrile Neutropenia (2008) (98)
- ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients (2019) (93)
- Critical Stages of Extracting DNA from Aspergillus fumigatus in Whole-Blood Specimens (2010) (92)
- Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents (2003) (90)
- A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus (2004) (89)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. (2012) (89)
- Molecular Detection and Identification of Zygomycetes Species from Paraffin-Embedded Tissues in a Murine Model of Disseminated Zygomycosis: a Collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) Evaluation (2010) (87)
- Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. (2011) (86)
- Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside. (2014) (85)
- Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst. (2011) (85)
- In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp (2003) (84)
- EUCAST technical note on fluconazole. (2008) (84)
- In Vitro Activities of 35 Double Combinations of Antifungal Agents against Scedosporium apiospermum and Scedosporium prolificans (2008) (83)
- Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. (2013) (81)
- Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus (2005) (80)
- Genetic Similarity among One Aspergillus flavus Strain Isolated from a Patient Who Underwent Heart Surgery and Two Environmental Strains Obtained from the Operating Room (2000) (79)
- Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers (2009) (75)
- Interlaboratory Evaluation of Hematocytometer Method of Inoculum Preparation for Testing Antifungal Susceptibilities of Filamentous Fungi (2003) (74)
- Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. (2008) (73)
- Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles in Aspergillus species. Stockholm: ECDC; 2013 (2013) (73)
- Paradoxical Growth of Candida albicans in the Presence of Caspofungin Is Associated with Multiple Cell Wall Rearrangements and Decreased Virulence (2013) (72)
- European expert opinion on the management of invasive candidiasis in adults. (2011) (71)
- Update on the epidemiology and diagnosis of invasive fungal infection. (2008) (71)
- Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing ofCandida spp (2001) (70)
- Susceptibility Testing and Molecular Classification of Paecilomyces spp (2008) (70)
- Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. (2005) (70)
- In vitro susceptibility of Cryptococcus gattii clinical isolates. (2008) (70)
- Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method (2013) (70)
- Changes in the epidemiological landscape of invasive mould infections and disease (2017) (70)
- In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis (2006) (70)
- Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease. (2013) (69)
- Correction: Fungal Cell Gigantism during Mammalian Infection (2010) (69)
- Impact of early central venous catheter removal on outcome in patients with candidaemia. (2007) (69)
- In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing (2008) (68)
- Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia (2009) (67)
- Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. (2005) (66)
- Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri (2009) (66)
- Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection (2020) (65)
- Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species (2014) (63)
- Burden of serious fungal infections in Spain. (2015) (63)
- Identification of Pathogenic Rare Yeast Species in Clinical Samples: Comparison between Phenotypical and Molecular Methods (2010) (63)
- Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. (2015) (62)
- Transient Fungemia Caused by an Amphotericin B-Resistant Isolate of Candida haemulonii (2002) (62)
- Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In Vitro (2008) (61)
- Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. (2006) (61)
- EUCAST technical note on voriconazole and Aspergillus spp. (2013) (61)
- Statistical Analyses of Correlation between Fluconazole MICs for Candida spp. Assessed by Standard Methods Set Forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2) (2006) (60)
- Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. (2000) (60)
- Genotyping and Antifungal Susceptibility Profile of Dipodascus capitatus Isolates Causing Disseminated Infection in Seven Hematological Patients of a Tertiary Hospital (2004) (59)
- The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro (2010) (59)
- Prevalence and Susceptibility Testing of New Species of Pseudallescheria and Scedosporium in a Collection of Clinical Mold Isolates (2006) (58)
- Echinocandin Susceptibility Testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots (2011) (58)
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project (2019) (58)
- Increasing Incidence of Invasive Aspergillosis in Pediatric Hematology Oncology Patients Over the Last Decade: A Retrospective Single Centre Study (2009) (57)
- Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. (2014) (57)
- Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. (2000) (56)
- Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain. (2010) (56)
- Detection of imported histoplasmosis in serum of HIV-infected patients using a real-time PCR-based assay (2006) (56)
- Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review. (2010) (55)
- Development and Validation of a Quantitative PCR Assay for Diagnosis of Scedosporiosis (2008) (54)
- Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996-1999. (2002) (54)
- EUCAST technical note on anidulafungin. (2011) (53)
- In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota. (2003) (53)
- Standardization of Antifungal Susceptibility Variables for a Semiautomated Methodology (2001) (51)
- Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia. (2013) (51)
- In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi. (2004) (51)
- In Vitro Activity of Ravuconazole against 923 Clinical Isolates of Nondermatophyte Filamentous Fungi (2005) (50)
- Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp. (2006) (50)
- Flucytosine Primary Resistance in Candida Species and Cryptococcus neoformans (2001) (50)
- Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds (2009) (49)
- Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST (2007) (49)
- EUCAST breakpoints for antifungals. (2010) (48)
- Comparative in Vitro Activity of Voriconazole and Itraconazole Against Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida Species from Spain (1999) (48)
- In Vitro Activities of Ravuconazole and Four Other Antifungal Agents against Fluconazole-Resistant or -Susceptible Clinical Yeast Isolates (2004) (48)
- Incidence of zygomycosis in transplant recipients. (2009) (48)
- Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). (2011) (47)
- Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans: a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI–2% Glucose (2000) (47)
- The Interaction between Candida krusei and Murine Macrophages Results in Multiple Outcomes, Including Intracellular Survival and Escape from Killing (2011) (46)
- Performance of Panfungal- and Specific-PCR-Based Procedures for Etiological Diagnosis of Invasive Fungal Diseases on Tissue Biopsy Specimens with Proven Infection: a 7-Year Retrospective Analysis from a Reference Laboratory (2014) (46)
- Utility of real-time PCR for the detection of Paracoccidioides brasiliensis DNA in the diagnosis of imported paracoccidioidomycosis. (2009) (46)
- In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. (2010) (46)
- In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp. (1999) (46)
- Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America (2018) (46)
- Analysis of the Influence of Tween Concentration, Inoculum Size, Assay Medium, and Reading Time on Susceptibility Testing of Aspergillus spp (2005) (45)
- In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. (2001) (44)
- In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies. (2019) (44)
- Fungemia due to rare opportunistic yeasts: data from a population‐based surveillance in Spain (2017) (43)
- New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains. (2006) (43)
- Evaluation by Data Mining Techniques of Fluconazole Breakpoints Established by the Clinical and Laboratory Standards Institute (CLSI) and Comparison with Those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2010) (43)
- Current section and species complex concepts in Aspergillus: recommendations for routine daily practice (2012) (42)
- Role of Aspergillus lentulus 14-α Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility (2011) (42)
- EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole (2014) (42)
- Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints. (2012) (41)
- Comparison of PCR protocols for detecting Histoplasma capsulatum DNA through a multicenter study. (2013) (41)
- HPLC/UV or bioassay: two valid methods for posaconazole quantification in human serum samples. (2012) (41)
- Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia. (2017) (41)
- Comparison of Visual 24-Hour and Spectrophotometric 48-Hour MICs to CLSI Reference Microdilution MICs of Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Candida spp.: a Collaborative Study (2005) (40)
- Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. (2007) (40)
- Resistance to Voriconazole Due to a G448S Substitution in Aspergillus fumigatus in a Patient with Cerebral Aspergillosis (2012) (40)
- Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance. (2015) (40)
- Analytical Comparison of In Vitro-Spiked Human Serum and Plasma for PCR-Based Detection of Aspergillus fumigatus DNA: a Study by the European Aspergillus PCR Initiative (2015) (39)
- Clinical Case of Endocarditis due to Trichosporon inkin and Antifungal Susceptibility Profile of the Organism (2004) (39)
- Erratum: The European Committee on antimicrobial susceptibility testing - Subcommittee on antifungal susceptibility testing (EUCAST-AFST)*. EUCAST technical note on fluconazole (Clinical Microbiology and Infection (2008) vol. 14(2) (193-195)) (2009) (39)
- An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance. (2014) (38)
- Process Analysis of Variables for Standardization of Antifungal Susceptibility Testing of Nonfermentative Yeasts (2011) (38)
- Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. (2008) (38)
- Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort. (2016) (38)
- Present status of the detection of antifungal resistance: the perspective from both sides of the ocean. (2001) (37)
- Disseminated Fusariosis Caused by Fusarium verticillioides in an Acute Lymphoblastic Leukemia Patient after Allogeneic Hematopoietic Stem Cell Transplantation (2008) (37)
- [Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update]. (2011) (35)
- Disseminated adiaspiromycosis: case report of a liver transplant patient with human immunodeficiency infection, and literature review (2011) (35)
- Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI. (2019) (34)
- Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia. (2011) (34)
- Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E‐test (2010) (34)
- Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium (2015) (34)
- Bordetella hinzii, a "new" opportunistic pathogen to think about. (2000) (33)
- EUCAST technical note on Amphotericin B. (2011) (33)
- Differences in Interactions between Azole Drugs Related to Modifications in the 14-α Sterol Demethylase Gene (cyp51A) of Aspergillus fumigatus (2005) (32)
- Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiae. (2011) (31)
- Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia (2017) (31)
- Data Mining Validation of Fluconazole Breakpoints Established by the European Committee on Antimicrobial Susceptibility Testing (2009) (30)
- High-Resolution Melting Analysis for Identification of the Cryptococcus neoformans-Cryptococcus gattii Complex (2011) (30)
- Determining the analytical specificity of PCR‐based assays for the diagnosis of IA: What is Aspergillus? (2016) (30)
- Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study) (2018) (30)
- Clinical relevance of resistance to antifungals. (2008) (30)
- Detection of invasive infection caused by Fusarium solani and non-Fusarium solani species using a duplex quantitative PCR-based assay in a murine model of fusariosis. (2012) (30)
- Recurrent Episodes of Candidemia Due to Candida glabrata with a Mutation in Hot Spot 1 of the FKS2 Gene Developed after Prolonged Therapy with Caspofungin (2012) (30)
- EUCAST technical note on posaconazole. (2011) (30)
- In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms (2015) (29)
- Characterization of a possible nosocomial aspergillosis outbreak. (2000) (29)
- Analysis of Performance of a PCR-Based Assay To Detect DNA of Aspergillus fumigatus in Whole Blood and Serum: a Comparative Study with Clinical Samples (2011) (29)
- Vulvovaginal candidiasis in a Flemish patient population. (2005) (28)
- [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]. (2011) (28)
- EUCAST and CLSI: Working Together Towards a Harmonized Method for Antifungal Susceptibility Testing (2013) (27)
- Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients. (2012) (27)
- Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain. (2016) (27)
- Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia. (2013) (26)
- Antifungal Susceptibility Profile of Human-Pathogenic Species of Lichtheimia (2010) (26)
- Recurrent Disseminated Skin Lesions Due to Metarrhizium anisopliae in an Adult Patient with Acute Myelogenous Leukemia (2006) (25)
- Detection of fungal DNA by real-time polymerase chain reaction: evaluation of 2 methodologies in experimental pulmonary aspergillosis. (2006) (25)
- Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method. (2018) (25)
- In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies (2019) (25)
- Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections (2016) (24)
- [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]. (1999) (24)
- Aspergillus alliaceus and Aspergillus flavus co-infection in an acute myeloid leukemia patient. (2010) (24)
- Epidemiology and prognosis of candidaemia in elderly patients (2017) (23)
- Acute respiratory distress syndrome due to Cryptococcus albidus pneumonia: case report and review of the literature. (2007) (23)
- Molecular identification and susceptibility profile in vitro of the emerging pathogen Candida kefyr. (2010) (23)
- Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections (2005) (23)
- Diagnostics and susceptibility testing in Aspergillus. (2016) (23)
- Comparison of Dimethyl Sulfoxide and Water as Solvents for Echinocandin Susceptibility Testing by the EUCAST Methodology (2012) (22)
- Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction. (2011) (22)
- Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance. (2017) (22)
- Frequency of Voriconazole Resistance In Vitro among Spanish Clinical Isolates of Candida spp. According to Breakpoints Established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (2011) (22)
- Development and validation of a quantitative real-time PCR assay for the early diagnosis of coccidioidomycosis. (2014) (22)
- Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study) (2017) (22)
- A second look at Emmonsia infection can make the difference (2014) (21)
- Imported acute histoplasmosis with rheumatologic manifestations in Spanish travelers. (2007) (19)
- [Current epidemiology and laboratory diagnosis of endemic mycoses in Spain]. (2012) (19)
- [Assessment of a quantitative PCR method for clinical diagnosis of imported histoplasmosis]. (2007) (19)
- Pharmacotherapy of yeast infections. (2008) (18)
- Pharmacotherapy of yeast infections (2008) (18)
- In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies. (2020) (17)
- Development and validation of a fast HPLC/photodiode array detection method for the measurement of voriconazole in human serum samples. A reference laboratory experience. (2013) (17)
- Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors. (2018) (17)
- EUCAST and CLSI: How to Assess in Vitro Susceptibility and Clinical Resistance (2012) (16)
- Invasive Fungal Infections Supplement ESCMID / ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast Infections (2013) (16)
- Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications (2011) (15)
- [Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi]. (2010) (15)
- [Infection and colonization by Scedosporium prolificans]. (2001) (15)
- Time of Incubation for Antifungal Susceptibility Testing of Aspergillus fumigatus: Can MIC Values Be Obtained at 24 Hours? (2007) (15)
- Detection of Resistance to Amphotericin B inCandida Isolates by Using Iso-Sensitest Broth (2001) (15)
- Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis (2016) (14)
- The management of febrile neutropenia in the posaconazole era: a new challenge? (2012) (14)
- Development and Validation of a High-Resolution Melting Assay To Detect Azole Resistance in Aspergillus fumigatus (2017) (14)
- Polyphasic characterization of fungal isolates from a published case of invasive aspergillosis reveals misidentification of Aspergillus felis as Aspergillus viridinutans. (2014) (14)
- Antifúngicos para uso sistémico (2009) (13)
- [Should antifungal treatments be based upon results of antifungal susceptibility testing?]. (2002) (13)
- Analysis of strain relatedness using High Resolution Melting in a case of recurrent candiduria (2013) (13)
- EUCAST Testing of Isavuconazole Susceptibility in Aspergillus: Comparison of Results for Inoculum Standardization Using Conidium Counting versus Optical Density (2014) (13)
- Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection. (2021) (13)
- Pharmacokinetics of Echinocandins in Suspected Candida Peritonitis: a Potential Risk for Resistance. (2020) (12)
- [Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update]. (2011) (12)
- Ribosomic DNA intergenic spacer 1 region is useful when identifying Candida parapsilosis spp. complex based on high-resolution melting analysis. (2014) (11)
- A case of primary cutaneous histoplasmosis acquired in the laboratory (2011) (11)
- Determination of Voriconazole Serum Concentration by Bioassay, a Valid Method for Therapeutic Drug Monitoring for Clinical Laboratories (2013) (11)
- [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing]. (2007) (11)
- Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system (2014) (11)
- [Epidemiological survey of dermatophytosis in Spain (April-June 2001)]. (2003) (11)
- In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies (2021) (11)
- [Antifungals for systemic use]. (2009) (10)
- Evaluation of MALDI-TOF-MS for the Identification of Yeast Isolates Causing Bloodstream Infection. (2017) (10)
- EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates (2019) (10)
- A simple, sensitive HPLC-PDA method for the quantification of itraconazole and hydroxy itraconazole in human serum: a reference laboratory experience. (2013) (10)
- Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study (2021) (10)
- In vitro antifungal susceptibility pattern and ergosterol content in clinical yeast strains. (2011) (10)
- Changes in susceptibility ofSalmonella enteritidis, Salmonella typhimurium, andSalmonella virchow to six antimicrobial agents in a Spanish hospital, 1980–1994 (2005) (10)
- Cutaneous listeriosis in a patient infected with the human immunodeficiency virus. (1994) (10)
- Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study (2017) (9)
- [Soft-tissue infection caused by Aeromonas hydrophila]. (1995) (9)
- Comparison of Caspofungin MICs by Means of EUCAST Method EDef 7.1 Using Two Different Concentrations of Glucose (2010) (9)
- The Capsule of the Fungal Pathogen Cryptococcus neoformans Paradoxically Inhibits Invasive Growth (2008) (9)
- Fungal infection in solid organ recipients. (2012) (9)
- Multicenter Comparison of the ISO Standard 20776-1 and the Serial 2-Fold Dilution Procedures To Dilute Hydrophilic and Hydrophobic Antifungal Agents for Susceptibility Testing (2010) (8)
- [Regional laboratory network for surveillance of invasive fungal infections and antifungal susceptibility in Latin America]. (2008) (8)
- Pneumococcal soft-tissue infections. (1995) (8)
- Defining standards of CARE for invasive fungal diseases in the ICU (2019) (8)
- Isolation of Cunninghamella blakesleeana in an immunodepressed patient (2012) (8)
- Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis (2020) (7)
- [Molecular techniques in mycology]. (2008) (7)
- Executive Summary of the 2017 ESCMID -ECMM Guideline for the Diagnosis and Management of Aspergillus Disease (2018) (7)
- [Laboratory diagnosis of fungal infection diseases]. (2012) (7)
- Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient (2004) (7)
- Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. (2006) (6)
- [Guidelines for fungal diagnoses and antifungal sensitivity studies]. (2004) (6)
- ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases. (2012) (6)
- When to change treatment of acute invasive aspergillosis: an expert viewpoint (2021) (6)
- [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances]. (2010) (6)
- [Epidemiological profile of non-typhi salmonellosis in a hospital in urban Madrid (1980-1994)]. (1996) (6)
- Granulomatous infection due toPropionibacterium acnes mimicking malignant disease (1994) (6)
- Azasordarins: Susceptibility of Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates ofCandida spp. to GW 471558 (2001) (6)
- Reliability of the WIDERYST Susceptibility Testing System for Detection of In Vitro Antifungal Resistance in Yeasts (2008) (6)
- [Cryptococcus gattii meningitis: observation in a Spanish patient]. (2008) (5)
- Can We Achieve Clinical Breakpoints for the Triazoles in Aspergillosis? (2011) (5)
- [Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi]. (2002) (5)
- Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls. (2005) (4)
- [Detection of Aspergillus spp. by real-time PCR in a murine model of pulmonary infection]. (2005) (4)
- Roles of the multiplex real-time PCR assay and β-D-glucan in a high-risk population for intra-abdominal candidiasis (IAC). (2019) (4)
- Erratum to: Antifungal Susceptibility Profile of Cryptic Species of Aspergillus (2015) (4)
- Eikenella corrodens thumb osteomyelitis. (1996) (4)
- A European prospective invasive mould disease audit (2014) (4)
- [Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection]. (2014) (4)
- ARE COMBINATIONS OF ANTIFUNGALS BENEFICIAL OR DELETERIOUS (2003) (3)
- [Antifungal susceptibility testing in yeasts. Update and novelties]. (2013) (3)
- Faculty Opinions recommendation of Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. (2006) (3)
- Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium (2020) (3)
- Nosocomially acquired bacteremia caused by Serratia plymuthica (1995) (3)
- [Are molecular techniques useful in aspergillosis surveillance and control?]. (2003) (2)
- Identification of Two Different 14-α Sterol Demethylase-Related Genes ( and ) in and Other Species. (2001) (2)
- [Pseudozyma sp.: colonizer of the respiratory tract in critical patients]. (2003) (2)
- Reclassification of the Candida haemulonii complex; C. 1 duobushaemulonii sp. nov. ( C. haemulonii group II) and C. 2 haemulonii var . vulnera var. nov.: Two multiresistant human 3 pathogenic yeasts. 4 (2012) (2)
- Antifúngicos de uso sistémico y tópico. Nuevas moléculas antifúngicas (2002) (2)
- The production of reactive oxygen species is an universal action (2014) (2)
- Reply to Lewis et al. (2012) (2)
- Molecular identification of Trichosporon species. (2006) (2)
- An introduction to current standards of CARE in invasive fungal disease. (2019) (1)
- Bacteremic pyelonephritis caused by Sphingomonas paucimobilis (1994) (1)
- Pseudozyma sp.: colonizador de vías respiratorias en enfermos críticos (2003) (1)
- Galleria mellonella as a non conventional host to study virulence and antifungal efficacy during Candida krusei infection (2012) (1)
- Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011 (2014) (1)
- PARADOXICAL GROWTH TO CASPOFUNGIN IN Candida albicans IS 1 ASSOCIATED WITH MULTIPLE CELL WALL REARRANGEMENTS AND 2 DECREASED VIRULENCE (2013) (1)
- Identification of Two Different 14-α Sterol Demethylase-Related Genes (cyp51A and cyp51B) in Aspergillus fumigatus and Other AspergillusSpecies (2001) (1)
- [Candidemia: impact of epidemiological studies on the treatment and prognosis of a serious infection]. (2011) (1)
- [Molecular diagnosis of parasitic and fungal infections]. (2008) (1)
- Analysis of strain relatedness using High Resolution Melting in a case of recurrent candiduria (2013) (1)
- [Current status of invasive fungal infections. New diagnostic techniques and antifungal agents]. (2008) (1)
- Study in Spain in 2010 and 2011 Fungemia Collected in a Population-Based Susceptibility of Yeast Isolates Causing Molecular Identification and Antifungal (2014) (1)
- Aspergillus as a Human Pathogen: an Evolutionary Perspective (2008) (1)
- Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI (2019) (1)
- Susceptibility and Its Role in Azole Drug fumigatus Aspergillus ) in cyp 51 A Demethylase ( Sterol α Targeted Gene Disruption of the 14 (2005) (0)
- 353. Evaluation of the in vitro activity of amphotericin B used in the liposomal formulation AmBisome against contemporary human fungal pathogens (2022) (0)
- [Medical relevance of the identification of human pathogenic fungi to species level]. (2001) (0)
- ESCMID dagger and ECMM double dagger joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (2014) (0)
- Bordetella hinzii is another organism to be added to the long list of opportunistic bacteria for immunocompromised patients. (2000) (0)
- Report from the 5th Trends in Medical Mycology, Valencia, Spain, 2–5 October 2011 (2012) (0)
- Comparison of Dimethyl Sulfoxide and Water as Solvents for Echinocandin Susceptibility Testing by the EUCAST Methodology (2012) (0)
- High-Resolution Melting Analysis for Identification of the Cryptococcus neoformans-Cryptococcus gattii Complex (cid:1) (2011) (0)
- Faculty Opinions recommendation of A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. (2006) (0)
- Faculty Opinions recommendation of Polymerase chain reaction screening for fungemia and/or invasive fungal infections in patients with hematologic malignancies. (2006) (0)
- Faculty Opinions recommendation of In vitro activity and in vivo efficacy of icofungipen (PLD-118), a novel oral antifungal agent, against the pathogenic yeast Candida albicans. (2006) (0)
- Erratum to: Antifungal Susceptibility Profile of Cryptic Species of Aspergillus (2014) (0)
- Antifungal Susceptibility Testing and Therapy (2010) (0)
- GUEST COMMENTARY Sequence-Based Identification of Aspergillus , Fusarium , and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? (cid:1) (2009) (0)
- P1970 In vitro susceptibility of clinical isolates of Cryptococcus gattii (2007) (0)
- Specimens in Whole-Blood Aspergillus fumigatus Critical Stages of Extracting DNA from (2014) (0)
- Faculty Opinions recommendation of Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. (2005) (0)
- Candida Fluconazole-Resistant Clinical Isolates of Fluconazole-Susceptible and Azasordarins : Susceptibility of (2001) (0)
- Method for the simultaneous detection of Histoplasma capsulatum and Paracoccidioides brasiliensis. (2008) (0)
- Antifungal Susceptibility Profile of Cryptic Species of Aspergillus (2014) (0)
- Online‐Only Abstracts (2011) (0)
- [Extravascular infections caused by Streptococcus adjacens. Report of 2 cases]. (1994) (0)
- Correspondence Molecular Identification of Trichosporon Species (2006) (0)
- Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system (2014) (0)
- [Systemic yeast infections in a general hospital. Correlation between study of susceptibility in vitro and patient survival to the fungal infection episode]. (2002) (0)
- Minimal inhibitory concentration distributions and epidemiological cut-offs of amphotericin B, flucytosine, fluconazole, itraconazole and voriconazole for Candida spp. using the EUCAST methodology for susceptibility testing (2008) (0)
- Molecular identification of Trichosporon species. Authors' reply (2006) (0)
- Online‐Only Abstracts (2011) (0)
- Role of Aspergillus lentulus 14- (cid:1) Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility (cid:1) (2011) (0)
This paper list is powered by the following services:
